1. Home
  2. EDIT vs GIW Comparison

EDIT vs GIW Comparison

Compare EDIT & GIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

N/A

Current Price

$1.63

Market Cap

422.3M

Sector

Health Care

ML Signal

N/A

Logo GigCapital8 Corp. Class A Ordinary Shares

GIW

GigCapital8 Corp. Class A Ordinary Shares

N/A

Current Price

$10.23

Market Cap

371.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EDIT
GIW
Founded
2013
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
422.3M
371.3M
IPO Year
2016
2025

Fundamental Metrics

Financial Performance
Metric
EDIT
GIW
Price
$1.63
$10.23
Analyst Decision
Buy
Analyst Count
13
0
Target Price
★ $6.10
N/A
AVG Volume (30 Days)
★ 2.2M
41.6K
Earning Date
11-09-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 37.50
N/A
EPS
N/A
★ N/A
Revenue
★ $31,937,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 132.64
N/A
52 Week Low
$1.66
$9.87
52 Week High
$3.94
$10.24

Technical Indicators

Market Signals
Indicator
EDIT
GIW
Relative Strength Index (RSI) 29.08 73.83
Support Level N/A $9.96
Resistance Level $3.00 N/A
Average True Range (ATR) 0.21 0.01
MACD -0.09 0.00
Stochastic Oscillator 1.10 90.00

Price Performance

Historical Comparison
EDIT
GIW

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

About GIW GigCapital8 Corp. Class A Ordinary Shares

GigCapital8 Corp is a blank check company.

Share on Social Networks: